PD-L1 is a PD-1 ligand blocking the interaction between the tumor cells expressing PD-L1 and tumor-specific T cells expressing PD-1 using PD-1 or PD-L1 antibodies enhance the cytolytic activity of T cells (25). Here, PDCD1 is linked to neoplasm.